Latest Insider Transactions at Rani Therapeutics Holdings, Inc. (RANI)
This section provides a real-time view of insider transactions for Rani Therapeutics Holdings, Inc. (RANI). The data is sourced from Form 4 filings with the SEC, which are filed by insiders of Rani Therapeutics Holdings, Inc. to disclose their transactions in the company's securities. By reviewing this information, investors can gain insights into the trading activity of Rani Therapeutics Holdings, Inc.'s insiders and make more informed investment decisions.
Insider Transaction List
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Mar 07
2022
|
Mir A Imran |
BUY
Conversion of derivative security
|
Indirect |
2,309,490
+49.28%
|
-
|
|
Mar 07
2022
|
Mir A Imran |
SELL
Conversion of derivative security
|
Indirect |
2,309,490
-9.25%
|
-
|
|
Mar 07
2022
|
Andrew Farquharson |
SELL
Other acquisition or disposition
|
Indirect |
2,229,238
-93.84%
|
-
|
|
Mar 07
2022
|
Andrew Farquharson |
BUY
Conversion of derivative security
|
Indirect |
2,309,490
+49.29%
|
-
|
|
Mar 07
2022
|
Andrew Farquharson |
SELL
Conversion of derivative security
|
Indirect |
2,309,490
-90.0%
|
-
|
|
Feb 03
2022
|
In Cube Labs, L.L.C. > 10% Shareholder |
BUY
Other acquisition or disposition
|
Direct |
13,923
+50.0%
|
-
|
|
Feb 03
2022
|
Andrew Farquharson |
BUY
Other acquisition or disposition
|
Indirect |
66,127
+50.0%
|
-
|
|
Feb 03
2022
|
Andrew Farquharson |
SELL
Other acquisition or disposition
|
Indirect |
827,467
-100.0%
|
-
|
|
Feb 03
2022
|
Maulik Nanavaty |
BUY
Other acquisition or disposition
|
Indirect |
11,017
+50.0%
|
-
|
|
Feb 03
2022
|
Mir A Imran |
BUY
Other acquisition or disposition
|
Indirect |
67,707
+50.0%
|
-
|
|
Feb 03
2022
|
Mir A Imran |
SELL
Other acquisition or disposition
|
Indirect |
827,467
-100.0%
|
-
|
|
Feb 03
2022
|
Talat Imran Chief Executive Officer |
BUY
Other acquisition or disposition
|
Indirect |
12,343
+50.0%
|
-
|
|
Feb 03
2022
|
Talat Imran Chief Executive Officer |
SELL
Other acquisition or disposition
|
Indirect |
827,467
-100.0%
|
-
|
|
Sep 09
2021
|
Mir Hashim Chief Scientific Officer |
BUY
Grant, award, or other acquisition
|
Direct |
117,600
+50.0%
|
-
|
|
Sep 09
2021
|
Svai S Sanford Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
106,200
+50.0%
|
-
|
|
Aug 03
2021
|
Moreno Isidoro Quiroga > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
6,300,000
+24.2%
|
$69,300,000
$11.0 P/Share
|
|
Jul 30
2021
|
Moreno Isidoro Quiroga > 10% Shareholder |
BUY
Open market or private purchase
|
Indirect |
158,904
+2.84%
|
$1,747,944
$11.25 P/Share
|